• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活素A对血管内皮细胞生长的抑制作用。

Inhibition of vascular endothelial cell growth by activin-A.

作者信息

McCarthy S A, Bicknell R

机构信息

Imperial Cancer Research Fund Laboratories, University of Oxford, John Radcliffe Hospital, United Kingdom.

出版信息

J Biol Chem. 1993 Nov 5;268(31):23066-71.

PMID:8226823
Abstract

The demonstration of type 2 activin receptor expression in human umbilical vein endothelial cells prompted an investigation of the effects of the activin/inhibin family of hormones on vascular endothelial cell growth. Recombinant activin-A inhibited [3H]methylthymidine uptake and growth of a panel of endothelial cell types; recombinant inhibin-A was without effect. Affinity cross-linking studies demonstrated the presence of type 1 and type 2 activin receptors on the surface of bovine aortic endothelial cells, while detailed analysis of type 2 activin receptor expression revealed both type 2 and type 2B activin receptor mRNA in all endothelial cell types analyzed. In addition, capillary endothelial cells were found to express activin-beta A subunit mRNA and protein, the levels of which were increased in response to transforming growth factor (TGF)-beta. Furthermore, activin-A and TGF-beta caused additive inhibition of capillary endothelial cell [3H]methylthymidine uptake. These findings implicate the activins in the regulation of endothelial cell function, and suggest that TGF-beta and activin may interact to inhibit capillary endothelial cell growth.

摘要

在人脐静脉内皮细胞中2型激活素受体表达的证实促使人们研究激活素/抑制素家族激素对血管内皮细胞生长的影响。重组激活素-A抑制了一组内皮细胞类型的[3H]甲基胸苷摄取和生长;重组抑制素-A则无作用。亲和交联研究表明牛主动脉内皮细胞表面存在1型和2型激活素受体,而对2型激活素受体表达的详细分析显示,在所有分析的内皮细胞类型中均存在2型和2B型激活素受体mRNA。此外,发现毛细血管内皮细胞表达激活素-βA亚基mRNA和蛋白,其水平在转化生长因子(TGF)-β刺激下升高。此外,激活素-A和TGF-β对毛细血管内皮细胞[3H]甲基胸苷摄取产生相加性抑制作用。这些发现表明激活素参与内皮细胞功能的调节,并提示TGF-β和激活素可能相互作用以抑制毛细血管内皮细胞生长。

相似文献

1
Inhibition of vascular endothelial cell growth by activin-A.激活素A对血管内皮细胞生长的抑制作用。
J Biol Chem. 1993 Nov 5;268(31):23066-71.
2
Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.I 型受体决定了对转化生长因子β和激活素的生长抑制及转录反应。
Mol Cell Biol. 1994 Jun;14(6):3810-21. doi: 10.1128/mcb.14.6.3810-3821.1994.
3
Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism.抑制素通过显性负性机制拮抗激活素对肝细胞生长的抑制作用。
J Biol Chem. 1995 Mar 17;270(11):6308-13. doi: 10.1074/jbc.270.11.6308.
4
Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.大鼠垂体肿瘤细胞系GH3中转化生长因子β和激活素的I型丝氨酸-苏氨酸激酶受体的分子特征
Exp Cell Res. 1995 Jan;216(1):208-14. doi: 10.1006/excr.1995.1026.
5
Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors.鉴定可与II型受体形成异源激酶复合物的人激活素和转化生长因子β I型受体。
Cell. 1993 Nov 19;75(4):671-80. doi: 10.1016/0092-8674(93)90488-c.
6
Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells.激活素A对抑制素/激活素亚基信使核糖核酸(mRNA)的调节及激活素受体mRNA在培养的人颗粒黄体细胞中的表达
Endocrinology. 1995 Oct;136(10):4382-9. doi: 10.1210/endo.136.10.7664658.
7
Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.激活素和抑制素对I型和II型激活素受体的配体依赖性异源二聚化以及人类红细胞分化具有拮抗作用。
Mol Cell Biol. 1997 Mar;17(3):1682-91. doi: 10.1128/MCB.17.3.1682.
8
Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.人卵巢癌细胞系中抑制素/激活素亚基、卵泡抑素及激活素II型受体的特性:自分泌生长调节中的潜在作用
Endocrinology. 1996 Feb;137(2):486-94. doi: 10.1210/endo.137.2.8593793.
9
Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE).激活素/抑制素亚基及激活素受体mRNA在正常及肿瘤性卵巢表面上皮(OSE)中的差异表达
Mol Cell Endocrinol. 2001 Mar 28;174(1-2):99-110. doi: 10.1016/s0303-7207(00)00447-0.
10
Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.通过转化生长因子-β或激活素的Ⅱ型受体来确定Ⅰ型受体的特异性
Science. 1993 Nov 5;262(5135):900-2. doi: 10.1126/science.8235612.

引用本文的文献

1
Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer.激活素水平与卵巢上皮性癌中的淋巴细胞浸润相关。
Cancer Med. 2024 Sep;13(17):e7368. doi: 10.1002/cam4.7368.
2
Evolving roles of activins and inhibins in ovarian cancer pathophysiology.激活素和抑制素在卵巢癌病理生理学中的作用演变。
Am J Physiol Cell Physiol. 2023 Feb 1;324(2):C428-C437. doi: 10.1152/ajpcell.00178.2022. Epub 2023 Jan 9.
3
Roles of follistatin-like protein 3 in human non-tumor pathophysiologies and cancers.卵泡抑素样蛋白3在人类非肿瘤病理生理学和癌症中的作用。
Front Cell Dev Biol. 2022 Oct 17;10:953551. doi: 10.3389/fcell.2022.953551. eCollection 2022.
4
Myostatin/Activin-A Signaling in the Vessel Wall and Vascular Calcification.血管壁中肌肉抑制素/激活素-A 信号转导与血管钙化。
Cells. 2021 Aug 12;10(8):2070. doi: 10.3390/cells10082070.
5
Dual Roles of the Activin Signaling Pathway in Pancreatic Cancer.激活素信号通路在胰腺癌中的双重作用
Biomedicines. 2021 Jul 14;9(7):821. doi: 10.3390/biomedicines9070821.
6
Follistatin impacts Tumor Angiogenesis and Outcome in Thymic Epithelial Tumors.卵泡抑素对胸腺癌血管生成和预后的影响。
Sci Rep. 2019 Nov 22;9(1):17359. doi: 10.1038/s41598-019-53671-8.
7
Retinal and choroidal angiogenesis: a review of new targets.视网膜和脉络膜血管生成:新靶点综述
Int J Retina Vitreous. 2017 Aug 21;3:31. doi: 10.1186/s40942-017-0084-9. eCollection 2017.
8
Hypoxia-induced activin A diminishes endothelial cell vasculogenic activity.缺氧诱导激活素 A 降低内皮细胞血管生成活性。
J Cell Mol Med. 2018 Jan;22(1):173-184. doi: 10.1111/jcmm.13306. Epub 2017 Aug 18.
9
Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.激活素受体2A型(ACVR2A)在成骨细胞中直接作为骨量的负调节因子发挥作用。
J Biol Chem. 2017 Aug 18;292(33):13809-13822. doi: 10.1074/jbc.M117.782128. Epub 2017 Jun 28.
10
TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment.转化生长因子-β、骨形态发生蛋白和激活素信号传导与肿瘤微环境
Cold Spring Harb Perspect Biol. 2017 May 1;9(5):a022285. doi: 10.1101/cshperspect.a022285.